🔎 Trials Near Me

Utama › Penyakit Sel Sabit › Wilayah Columbia

Kajian klinikal Penyakit Sel Sabit di Wilayah Columbia

10 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi di Wilayah Columbia.

Bandar di Wilayah Columbia

Teks kajian rasmi (Bahasa Inggeris)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Childrens National Hospital, Washington D.C.
Mengambil pesertaFasa 3
Umur 12 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06439082

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Childrens National Medical Ctr, Washington D.C.
  • MedStar Hlth Res Institute, Washington D.C.
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06612268

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Georgetown University, Washington D.C.
  • Children's National Hemophilia Center, Washington D.C.
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Children's National Medical Center, Washington D.C.
Mengambil pesertaKajian pemerhatian
Umur 4 hingga 65 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's National Hospital (MRD-HCT), Washington D.C.
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 20 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06941389

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Mengambil pesertaFasa 2
Umur 4 hingga 21 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06635902

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Children's National Health System, Washington D.C.
Mengambil pesertaFasa 2
Umur 2 hingga 25 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT03587272

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

  • Children's National Hospital, Washington D.C.
Mengambil pesertaFasa 2
Umur 2 hingga 25 · Semua jantina · Dikemas kini 26 Sep 2025 · NCT06358638

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Mengambil peserta
Umur 7 hingga 16 · Semua jantina · Dikemas kini 13 Feb 2025 · NCT06770010

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

  • Children's National Hospital, Washington D.C.
Mengambil peserta
Umur 8 hingga 16 · Semua jantina · Dikemas kini 10 Jan 2025 · NCT05099874

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.